Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
Novo Nordisk A/S
FTC sues drug brokers for allegedly inflating insulin prices
Federal Trade Commission (FTC) Chair Lina Khan testifies before the House Appropriations Subcommittee in the Rayburn House Office Building on…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Roche releases more data on slimming pills and injections
Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…
Eli Lilly to increase production of weight loss, diabetes and Alzheimer's drugs
A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…
57 million privately insured adults are eligible to receive GLP-1
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
Eli Lilly could become the first $1 trillion healthcare stock
A sign with the company logo is displayed outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, on…
Eli Lilly launches new, cheaper form of weight-loss drug
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City on December 11, 2023. Brendan…
Sesame to offer Wegovy compound through weight loss program
Healthcare marketplace Sesame announced Wednesday a new clinical weight loss program that will help eligible consumers access compounded versions of…
Eli Lilly weight-loss drug reduces diabetes risk in trial
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…